These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19733070)

  • 1. Selective inactivation of triosephosphate isomerase from Trypanosoma cruzi by brevifolin carboxylate derivatives isolated from Geranium bellum Rose.
    Gayosso-De-Lucio J; Torres-Valencia M; Rojo-Domínguez A; Nájera-Peña H; Aguirre-López B; Salas-Pacheco J; Avitia-Domínguez C; Téllez-Valencia A
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5936-9. PubMed ID: 19733070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: a deeper insight into the mechanism of inhibition.
    Alvarez G; Martínez J; Aguirre-López B; Cabrera N; Pérez-Díaz L; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Garat B; Merlino A; González M; Cerecetto H
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):198-204. PubMed ID: 23406473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The design and inhibitory profile of new benzimidazole derivatives against triosephosphate isomerase from Trypanosoma cruzi: a problem of residue motility.
    Romo-Mancillas A; Téllez-Valencia A; Yépez-Mulia L; Hernández-Luis F; Hernández-Campos A; Castillo R
    J Mol Graph Model; 2011 Sep; 30():90-9. PubMed ID: 21798779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of triosephosphate isomerase from Trypanosoma cruzi by an agent that perturbs its dimer interface.
    Téllez-Valencia A; Olivares-Illana V; Hernández-Santoyo A; Pérez-Montfort R; Costas M; Rodríguez-Romero A; López-Calahorra F; Tuena De Gómez-Puyou M; Gómez-Puyou A
    J Mol Biol; 2004 Aug; 341(5):1355-65. PubMed ID: 15321726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,2,4-thiadiazol-5(4H)-ones: a new class of selective inhibitors of Trypanosoma cruzi triosephosphate isomerase. Study of the mechanism of inhibition.
    Alvarez G; Aguirre-López B; Cabrera N; Marins EB; Tinoco L; Batthyány CI; de Gómez-Puyou MT; Puyou AG; Pérez-Montfort R; Cerecetto H; González M
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):981-9. PubMed ID: 22803666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking and molecular dynamics simulation studies of Trypanosoma cruzi triosephosphate isomerase inhibitors. Insights into the inhibition mechanism and selectivity.
    Minini L; Álvarez G; González M; Cerecetto H; Merlino A
    J Mol Graph Model; 2015 May; 58():40-9. PubMed ID: 25829097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity.
    Aguilera E; Varela J; Birriel E; Serna E; Torres S; Yaluff G; de Bilbao NV; Aguirre-López B; Cabrera N; Díaz Mazariegos S; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Minini L; Merlino A; Cerecetto H; González M; Alvarez G
    ChemMedChem; 2016 Jun; 11(12):1328-38. PubMed ID: 26492824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural considerations for the rational design of selective anti-trypanosomal agents: the role of the aromatic clusters at the interface of triosephosphate isomerase dimer.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Biochem Biophys Res Commun; 2005 Mar; 328(4):922-8. PubMed ID: 15707966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
    Alvarez G; Aguirre-López B; Varela J; Cabrera M; Merlino A; López GV; Lavaggi ML; Porcal W; Di Maio R; González M; Cerecetto H; Cabrera N; Pérez-Montfort R; de Gómez-Puyou MT; Gómez-Puyou A
    Eur J Med Chem; 2010 Dec; 45(12):5767-72. PubMed ID: 20889239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
    Neres J; Bryce RA; Douglas KT
    Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruzi.
    Téllez-Valencia A; Avila-Ríos S; Pérez-Montfort R; Rodríguez-Romero A; Tuena de Gómez-Puyou M; López-Calahorra F; Gómez-Puyou A
    Biochem Biophys Res Commun; 2002 Jul; 295(4):958-63. PubMed ID: 12127988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural differences in triosephosphate isomerase from different species and discovery of a multitrypanosomatid inhibitor.
    Olivares-Illana V; Pérez-Montfort R; López-Calahorra F; Costas M; Rodríguez-Romero A; Tuena de Gómez-Puyou M; Gómez Puyou A
    Biochemistry; 2006 Feb; 45(8):2556-60. PubMed ID: 16489748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the possible binding sites at the interface of triosephosphate isomerase dimer as a potential target for anti-tripanosomal drug design.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3151-4. PubMed ID: 15149664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics study of triosephosphate isomerase from Trypanosoma cruzi in water/decane mixtures.
    Díaz-Vergara N; Piñeiro A
    J Phys Chem B; 2008 Mar; 112(11):3529-39. PubMed ID: 18302363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi.
    Olivares-Illana V; Rodríguez-Romero A; Becker I; Berzunza M; García J; Pérez-Montfort R; Cabrera N; López-Calahorra F; de Gómez-Puyou MT; Gómez-Puyou A
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e1. PubMed ID: 17989778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible equilibrium unfolding of triosephosphate isomerase from Trypanosoma cruzi in guanidinium hydrochloride involves stable dimeric and monomeric intermediates.
    Chánez-Cárdenas ME; Pérez-Hernández G; Sánchez-Rebollar BG; Costas M; Vázquez-Contreras E
    Biochemistry; 2005 Aug; 44(32):10883-92. PubMed ID: 16086591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo.
    Álvarez G; Martínez J; Varela J; Birriel E; Cruces E; Gabay M; Leal SM; Escobar P; Aguirre-López B; Cabrera N; Tuena de Gómez-Puyou M; Gómez Puyou A; Pérez-Montfort R; Yaluff G; Torres S; Serna E; Vera de Bilbao N; González M; Cerecetto H
    Eur J Med Chem; 2015 Jul; 100():246-56. PubMed ID: 26094151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to proteolysis of triosephosphate isomerase from two pathogenic parasites: characterization of an enzyme with an intact and a nicked monomer.
    Reyes-Vivas H; Martínez-Martínez E; Mendoza-Hernández G; López-Velázquez G; Pérez-Montfort R; Tuena de Gómez-Puyou M; Gómez-Puyou A
    Proteins; 2002 Aug; 48(3):580-90. PubMed ID: 12112681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of the reactivation kinetics of homodimeric triosephosphate isomerase from unfolded monomers.
    Zomosa-Signoret V; Hernández-Alcántara G; Reyes-Vivas H; Martínez-Martínez E; Garza-Ramos G; Pérez-Montfort R; Tuena De Gómez-Puyou M; Gómez-Puyou A
    Biochemistry; 2003 Mar; 42(11):3311-8. PubMed ID: 12641463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in the Development of Triose Phosphate Isomerase Inhibitors as Antiprotozoal Agents.
    Vázquez-Jiménez LK; Moreno-Herrera A; Juárez-Saldivar A; González-González A; Ortiz-Pérez E; Paz-González AD; Palos I; Ramírez-Moreno E; Rivera G
    Curr Med Chem; 2022; 29(14):2504-2529. PubMed ID: 34517794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.